De controle op de productie van geneesmiddelen moet scherper en frequenter. Met name de controle op de productie buiten Europa moet beter, stelt voorzitter Gerben Klein Nulent van de apothekersorganisatie KNMP naar...

De malariaparasiet is voor het besmetten van nieuwe muggen sterk afhankelijk van een uniek eiwit. Dit eiwit kan een nieuw doel vormen voor de ontwikkeling van een geneesmiddel. Dat ontdekten onderzoekers van het...

After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, Jérôme Contamine, is set to retire before the end of the year.
 

Amgen has lifted the curtain on complete Phase 3 data for its calcitonin gene-related peptide receptor (CGRP) inhibitor Aimovig (erenumab) in the treatment of episodic migraine in patients who had previously failed two...

GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation within a briefing document prior to the FDA advisory committee meeting.
 

Veel mensen vinden het lastig om online op te vallen. Dat is niet zo gek. Volgens BuzzSumo wordt elk jaar weer meer content gepubliceerd dan het voorgaande jaar. Daarom is het nu meer dan ooit belangrijk om relevante en...

Het openbaar maken van financiële banden tussen zorgverleners en de farmaceutische industrie in Europa kan beter. Ook in Nederland is er nog onvoldoende transparantie, concluderen onderzoekers van universiteiten in...

Biologische medicijnen spelen een steeds grotere rol bij de behandeling van diverse aandoeningen. Ook krijgen patiënten mogelijk te maken met een overstap naar andere, soortgelijke biologische medicijnen: biosimilars.

Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase 3 trials in lung cancer and receiving a NICE approval.

Abbvie posted a strong showing this week from its JAK1 inhibitor upadacitinib, indicating that the drug outperformed even its own best-selling blockbuster Humira (adalimumab) at Phase 3 in the treatment of moderate to...

Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given approval by the European Commission to include an indication for Systemic...

Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business.

MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage III melanoma. It is the third such reveal in weeks, following the drug’s success as a...

GSK, a science─led global healthcare company, and Orchard Therapeutics, a privately held clinical─stage biotechnology company, both jointly announced a strategic agreement.

The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding the use of quinolone and fluoroquinolone antibiotics.
 

Sanofi has announced plans to spend €350 million on a new vaccine facility located in Toronto, Canada, a move which, according to the company, is one of its biggest-ever investments in a single building.
 

One of the major stumbling blocks that science has come up against, when trying to develop potential treatments for Alzheimer’s disease, is that promising trials results in mice have not translated so successfully into...

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with women how had the device implanted suggesting that they were had not been made aware of the risks.